US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ELECTRA THERAPEUTICS INC

9.16

-0.6600-6.72%

Pre-market: 8.81-0.3500-3.82%07:46 EDT

Volume:407.26K

Turnover:3.75M

Market Cap:559.68M

PE:0.00

High:9.73

Open:9.72

Low:8.92

Close:9.82

52wk High:15.50

52wk Low:8.92

Shares:61.10M

Float Shares:21.67M

Volume Ratio:0.58

T/O Rate:1.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2,163.6592

EPS(LYR):-1,408.5227

ROE:--

ROA:--

PB:-2.55

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Orbimed Advisors Llc Reports 11.0% Stake in Electra Therapeutics Inc as of Sept 21 - SEC Filing

THOMSON REUTERS

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

Major Insider Moves Signal Growing Confidence in Electra Therapeutics

OrbiMed Advisors Acquires 1,333,333 Electra Therapeutics Shares for USD 20 Million

Electra Therapeutics Files Form 3 as Westlake BioPartners Fund I Reports Beneficial Ownership

Electra Therapeutics Adopts Amended, Restated Bylaws Effective at IPO Close

Opening Day: Electra Therapeutics, Orion180 make market debuts

Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Electra Therapeutics indicated to open at $20, IPO priced at $15

Electra Therapeutics indicated to open at $16.25, IPO priced at $15

Electra Therapeutics IPO Expected to Raise $350 Million

MT Newswires Live

Immunology Biotech Electra Sets IPO at $15 Per Share, Raising $350 Million Ahead of Nasdaq Debut

Electra Therapeutics 23.33M share IPO priced at $15.00

Electra Therapeutics, - Therapeutics Prices Upsized IPO of 23,333,334 Shares at $15 Per Share

THOMSON REUTERS

Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering

THOMSON REUTERS

Immunology-Focused Biotech Electra Therapeutics Sets IPO Price Range at $14-$16 Per Share, Eyeing $325 Million Raise

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ETRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ETRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","market":"US","secType":"STK","nameCN":"ELECTRA THERAPEUTICS INC","latestPrice":9.16,"timestamp":1791403200000,"preClose":9.82,"halted":0,"volume":407261,"hourTrading":{"tag":"盘前","latestPrice":8.81,"preClose":9.16,"latestTime":"07:46 EDT","volume":5,"amount":48.580005,"timestamp":1791460000527,"change":-0.35,"changeRate":-0.03821,"amplitude":0.183406},"delay":0,"changeRate":-0.06720977596741345,"floatShares":21666667,"shares":61100300,"eps":-2163.6592,"marketStatus":"Pre-Mkt","change":-0.66,"latestTime":"10-08 08:52:42 EDT","open":9.72,"high":9.73,"low":8.92,"amount":3745470.271052,"amplitude":0.082485,"askPrice":11.95,"askSize":100,"bidPrice":3.67,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2163.6592,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1789704000000,"exchange":"NASDAQ","adjPreClose":9.16,"preHourTrading":{"tag":"盘前","latestPrice":8.81,"preClose":9.16,"latestTime":"07:46 EDT","volume":5,"amount":48.580005,"timestamp":1791460000527,"change":-0.35,"changeRate":-0.03821,"amplitude":0.183406},"postHourTrading":{"tag":"盘后","latestPrice":9.16,"preClose":9.16,"latestTime":"19:30 EDT","volume":2688,"amount":24622.1,"timestamp":1791415802219,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5837608637663141},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","floatShares":21666667,"roa":"--","roe":"--","lyrEps":-1408.522727,"volumeRatio":0.5837608637663141,"shares":61100300,"dividePrice":0,"high":9.73,"amplitude":0.082485,"preClose":9.82,"low":8.92,"week52Low":8.92,"pbRate":"-2.55","week52High":15.5,"institutionHeld":0,"latestPrice":9.16,"committee":0.333333,"eps":-2163.6592,"divideRate":0,"volume":407261,"delay":0,"ttmEps":-2163.6592,"open":9.72,"prevYearClose":15,"prevWeekClose":10.37,"prevMonthClose":11.25,"prevQuarterClose":11.25,"fiveDayClose":11.25,"twentyDayClose":15,"sixtyDayClose":15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETRA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ETRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ETRA","date":"2026-10-07","current":-0.004234,"percent":0.916667,"low":-10.215794,"twenty":-9.553823,"median":-8.329689,"eighty":-7.701476,"high":-7.14812,"avg":-8.544776,"sd":0.967808,"marketCap":616371498},"quantilePoints":[{"date":"2026-09-25","current":-8.674618,"twenty":-10.03966,"median":-9.724086,"eighty":-9.173666,"marketCap":741905408},{"date":"2026-10-02","current":-7.83798,"twenty":-9.778394,"median":-8.575543,"eighty":-8.297397,"marketCap":670351079},{"date":"2026-10-07","current":-7.206832,"twenty":-9.553823,"median":-8.329689,"eighty":-7.701476,"marketCap":616371498}],"updateTime":1791463962255},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ETRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670422108","title":"Orbimed Advisors Llc Reports 11.0% Stake in Electra Therapeutics Inc as of Sept 21 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670422108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670422108?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:26","pubTimestamp":1790371578,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H0LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442662","title":"ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442662","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442662?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353284,"startTime":"0","endTime":"0","summary":"UPDATE 2-ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPOSept 25 (Reuters)-Shares of ADARx PharmaceuticalsADRX.Orose 30% above their initial public offering price on Friday after th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H0ML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0942090050.USD","LU1989771016.USD","IE0009355771.USD","GLAM","LU0511384066.AUD","LU1003077747.HKD","LU2237443382.USD","FHLC","BK4585","IYH","LU0098860793.USD","LU0320765646.SGD","FTXH","LU2129689605.HKD","LU1839511570.USD","LU1548497426.USD","LU2023251221.USD","LU0545039389.USD","IE0000B7K699.USD","LU0058720904.USD","LU0912757837.SGD","IE00B42XCP33.USD","LU0158827948.USD","MEDX","IE00B19Z3581.USD","XLV","LU1037948897.HKD","ABBV","ADRX","JDOC","IE00B4R5TH58.HKD","LU1061106388.HKD","IXJ","LU2237443465.HKD","TRUH","LU0823416689.USD","LU0868494617.USD","LU1983299246.USD","PPH","LU0965509283.SGD","LU1670627923.USD","IE00BGHQF631.EUR","PJP","LU1929549753.HKD","RXL","VHT","AGNG","IE00BDGV0183.EUR","ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669045354","title":"Major Insider Moves Signal Growing Confidence in Electra Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2669045354","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669045354?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:01","pubTimestamp":1790215290,"startTime":"0","endTime":"0","summary":"New insider activity at Electra Therapeutics Inc. ( ($ETRA) ) has taken place on September 23, 2026. Electra Therapeutics Inc. has attracted notabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-electra-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-electra-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439758","title":"OrbiMed Advisors Acquires 1,333,333 Electra Therapeutics Shares for USD 20 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439758","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439758?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:30","pubTimestamp":1790199026,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 millionOrbiMed Advisors, a director and 10% owner, reported a sharp increase in its indirect stake in Electra Therapeutics.In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLbRGxBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OrbiMed Advisors Acquires 1,333,333 Electra Therapeutics Shares for USD 20 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669194300","title":"Electra Therapeutics Files Form 3 as Westlake BioPartners Fund I Reports Beneficial Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2669194300","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669194300?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:01","pubTimestamp":1790038905,"startTime":"0","endTime":"0","summary":"Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownershipElectra Therapeutics Form 3 filed Sept. 21, 2026, showing Westlake BioPartners entities reporting 10% benef","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1j3RJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669609198","title":"Electra Therapeutics Adopts Amended, Restated Bylaws Effective at IPO Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2669609198","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669609198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:01","pubTimestamp":1790020908,"startTime":"0","endTime":"0","summary":"Electra Therapeutics adopts amended, restated bylaws effective at IPO closeElectra Therapeutics adopted amended and restated bylaws effective Sept. 21, 2026 in connection with its IPO closing.Changes ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL1kZnWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669291198","title":"Opening Day: Electra Therapeutics, Orion180 make market debuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2669291198","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669291198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:00","pubTimestamp":1790020850,"startTime":"0","endTime":"0","summary":"Nscale Limited has filed for an IPO and aims to list on the New York Stock Exchange, as Electra Therapeutics and Orion180 Insurance made their mark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opening-day-electra-therapeutics-orion180-make-market-debuts-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opening-day-electra-therapeutics-orion180-make-market-debuts-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KCE","REDS","IPOS","IPO","BK4127","FRHC","ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669315794","title":"Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315794","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315794?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:32","pubTimestamp":1789986739,"startTime":"0","endTime":"0","summary":"UPDATE 3-Drug developer ADARx seeks $1.74 billion valuation in US IPOSept 21 (Reuters)-ADARx Pharmaceuticals, which develops RNA-based drugs for rare diseases, said on Monday that it was targeting a v","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU2237443978.SGD","LU0708994859.HKD","JDOC","BK4585","LU2237443465.HKD","IE0004445239.USD","LU0868494708.USD","LU0689626769.HKD","LU1989772923.USD","IE000BZT7R73.USD","LU2357627491.SGD","LU1023059063.AUD","XLV","LU0256863902.USD","MEDX","IE00B2B36J28.USD","LU0417517546.SGD","PPH","LU2433249047.HKD","LU2089283258.USD","RXL","VHT","LU1093756168.USD","IXJ","IE00BVYPNV92.GBP","LU0985320562.USD","PJP","LU2237443549.SGD","LU2133065610.SGD","IE00BGHQF631.EUR","LU2347655156.SGD","SG9999003800.SGD","FHLC","GLAM","SG9999015978.USD","TRUH","IYH","BK4581","LU0029864427.USD","BK4566","FTXH","LU1236620750.USD","AGNG","ABBV","ETRA","LU0289961442.SGD","LU1720051017.SGD","IE00BDGV0183.EUR","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668397655","title":"Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397655","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397655?lang=en_us&edition=fundamental","pubTime":"2026-09-19 06:26","pubTimestamp":1789770365,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continuesSept 18 (Reuters)-Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4N45A1OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU2552382132.HKD","LU0061475181.USD","LU0708995401.HKD","IE0001KFT4U8.USD","LU0198837287.USD","LU1548497426.USD","LU2106854487.HKD","SG9999018857.SGD","SG9999013999.USD","SGXZ57979304.SGD","CANC","LU1551013342.USD","IE00BJLML261.HKD","LU2213496289.HKD","ILDR","IE0009355771.USD","LU0225283273.USD","LU2360106947.USD","BK4007","LU0203201768.USD","LU0006306889.USD","LU0320765059.SGD","LU0882574139.USD","LU0466842654.USD","LU2756315664.SGD","LU2471134952.CNY","IE00BFTCPJ56.SGD","LU1712237335.SGD","GB00BDT5M118.USD","LU2461242641.AUD","IE00BKPKM429.USD","LU1629891620.HKD","IE00BKDWB100.SGD","LU2896262040.SGD","LU0323591593.USD","LU0133085943.USD","LU0820561818.USD","LU0889565916.HKD","SG9999014906.USD","LU0345770993.USD","SG9999015978.USD","SG9999017495.SGD","LU1551013425.SGD","LU2089284900.SGD","IHE","LU2087625088.SGD","LU1023059063.AUD","LU1989771016.USD","LU2168564222.USD","LU2456880835.USD","LU2168564495.EUR","LU2491050071.SGD","LU0210536198.USD","LU0456855351.SGD","LU2361045086.USD","LU2236285917.USD","IE00BN29S564.USD","LU0266013472.USD","LU0432979614.USD","TRUH","LU2750360997.AUD","LU2237443895.HKD","BK4581","LU2462591350.SGD","AGNG","BK4516","IE00B2B36J28.USD","IE00B7KXQ091.USD","IE0004445239.USD","LU0316494557.USD","LU0353189680.USD","LU0683600562.USD","LU1983299246.USD","BK4086","LU0256863811.USD","FTXH","LU1720051108.HKD","LU0345770308.USD","LU0096364046.USD","LU0158827781.USD","IE00BJT1NW94.SGD","LU1127390331.HKD","IE00BFSS7M15.SGD","LU2237443549.SGD","LU0079474960.USD","LU2471134796.USD","SGXZ31699556.SGD","LU2271345857.HKD","TMED","IE00B775H168.HKD","LLII","BK4585","LU1868836591.USD","IE00BJJMRX11.SGD","LU0786609619.USD","LU1093756325.SGD","LU0823434583.USD","IXJ","LU2089283258.USD","IE00B1XK9C88.USD","LU2264538146.SGD","IE00BK4W5M84.HKD","IE00BK4W5L77.USD","LU0289739699.SGD","LU0106261372.USD","LU1232071149.USD","IE0004445015.USD","IE00BJJMRZ35.SGD","LLYX","BK4127","LU1064131342.USD","ANT","LU1069344957.HKD","LU0094547139.USD","LU2552382058.USD","PJP","BK4588","LU1145028129.USD","LU0174119429.USD","IE0002141913.USD","MHIP","LU2491050154.USD","IE0005OL40V9.USD","IE00B4R5TH58.HKD","LU0256863902.USD","LU1804176565.USD","LU0820562030.AUD","THNR","LU2237443978.SGD","LU0109394709.USD","ELIS","PPH","LU0823434740.USD","LU2168563687.JPY","RXL","LU0234572021.USD","SG9999018865.SGD","SG9999015986.USD","LU2750360641.GBP","LLYZ","EVR","LU1868836914.USD","LU2471134879.HKD","FHLC","LU2602419157.SGD","LLY","GDOC","LU0417517546.SGD","LU0820561909.HKD","LU2237443382.USD","LU0114720955.EUR","LU2028103732.USD","LU0109391861.USD","SG9999014914.USD","LU0471298777.SGD","LU0097036916.USD","LU2168564065.EUR","IE00B1BXHZ80.USD","LU2211815571.USD","IE00BWXC8680.SGD","LU0385154629.USD","SGXZ81514606.USD","LU0471298694.HKD","JDOC","LU1720051017.SGD","LU1917777945.USD","BK4534","LU0787776722.HKD","ETRA","LU2023251221.USD","VHT","MEDI","LU2237443465.HKD","LU1814569148.SGD","LU0964807845.USD","IYH","SG9999014880.SGD","LU1979441026.SGD","SGXZ51526630.SGD","TREX","LU2361044949.HKD","SG9999015945.SGD","LU0354030511.USD","LU2468319806.SGD","LU2023250504.SGD","LU1868837300.USD","LU2357305700.SGD","LU1035775433.USD","LU1291159041.SGD","LU1323610961.USD","CURE","LU1057294990.SGD","LU2089984988.USD","LU2108987350.USD","LU1061106388.HKD","LU2265009873.SGD","SG9999015952.SGD","IE00BFSS8Q28.SGD","LU1988902786.USD","LU2417539215.USD","LU0354030438.USD","LU0238689110.USD","LU0689472784.USD","BK4599","LU2237443622.USD","IE00B4JS1V06.HKD","BK4533","LU1868837136.USD","LU2023250330.USD","LU0203202063.USD","LU2361044865.SGD","LU2462157665.USD","LU0943347566.SGD","LU0882574055.USD","LU1623119135.USD","LU2491049909.HKD","LU2746668974.SGD","LU0823416689.USD","IE00BJJMRY28.SGD","WDNA","LU2063271972.USD","LU2112291526.USD","LU0640476718.USD","SG9999014898.SGD","LU1366192091.USD","MEDX","LU0122379950.USD","XLV","SG9999001176.USD","LU2756315318.SGD","LU1267930730.SGD","LU2552382215.SGD","LU0353189763.USD","LU2471134523.USD","LU0058720904.USD","LU0672654240.SGD","LU1280957306.USD","OZEM","LU1093756168.USD","LU0158827948.USD","HRTS","LU1691799644.USD","LU2324357040.USD","LU2746668461.USD","SG9999001176.SGD","LU1974910355.USD","LU2168564149.EUR","SGXZ99366536.SGD","LU2237438978.USD","LU1868836757.USD","LU0320765992.SGD","LU2111349929.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668892453","title":"Electra Therapeutics indicated to open at $20, IPO priced at $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2668892453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668892453?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:55","pubTimestamp":1789743321,"startTime":"0","endTime":"0","summary":"Electra Therapeutics (ETRA), a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-20-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-20-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","XT","BK4127","FRHC","KCE","TMAT","WDNA","BK4588","SYNB","REDS","LFSC","MEDX","GNOM","IBB","BK4585","FDIF","IDNA","HELX","GDOC","IPOS","JDOC","PBE","BMED","GNMX","ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668924632","title":"Electra Therapeutics indicated to open at $16.25, IPO priced at $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2668924632","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668924632?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:55","pubTimestamp":1789743316,"startTime":"0","endTime":"0","summary":"10:54 EDT Electra Therapeutics (ETRA) indicated to open at $16.25, IPO priced at $15 Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-16-25-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-16-25-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REDS","ETRA","BK4127","IPO","IPOS","KCE","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668946012","title":"Electra Therapeutics IPO Expected to Raise $350 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668946012","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668946012?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:21","pubTimestamp":1789719672,"startTime":"0","endTime":"0","summary":"Electra Therapeutics  priced its upsized initial public offering of 23.3 million shares at $15 apiece for gross proceeds of about $350 million, the company said Thursday.The underwriters were granted a 30-day option to purchase up to an additional 3.5 million shares at the public offering price, the company said.The shares are expected to begin trading on Nasdaq on Friday under the ticker ETRA, with the offering expected to close Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPOS","FRHC","KCE","BK4127","REDS","ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169006508","title":"Immunology Biotech Electra Sets IPO at $15 Per Share, Raising $350 Million Ahead of Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1169006508","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169006508?lang=en_us&edition=fundamental","pubTime":"2026-09-18 15:01","pubTimestamp":1789714897,"startTime":"0","endTime":"0","summary":"Clinical-stage immunology drug developer Electra Therapeutics, Inc. has raised $350 million through an upsized U.S. initial public offering, pricing shares at the midpoint of its indicated range. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668915678","title":"Electra Therapeutics 23.33M share IPO priced at $15.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2668915678","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668915678?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:40","pubTimestamp":1789692007,"startTime":"0","endTime":"0","summary":"Jefferies, TD Cowen, Evercore ISI and Cantor Fitzgerald are acting as joint book running managers for the offering. The deal size was increased to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-23-33m-share-ipo-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-23-33m-share-ipo-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","KCE","ETRA","REDS","IPOS","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668913104","title":"Electra Therapeutics, - Therapeutics Prices Upsized IPO of 23,333,334 Shares at $15 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2668913104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668913104?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:30","pubTimestamp":1789691400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA3KRBPD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668102913","title":"Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2668102913","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668102913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:30","pubTimestamp":1789691400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA3KRBPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199621546","title":"Immunology-Focused Biotech Electra Therapeutics Sets IPO Price Range at $14-$16 Per Share, Eyeing $325 Million Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=1199621546","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199621546?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:28","pubTimestamp":1789457298,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology firm Electra Therapeutics, which is advancing targeted SIRP antibody therapies for immune disorders and oncology, unveiled the terms for its initial public offering on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","GDOC","BK4539","IBBJ","ETRA","IPOS","XBI","SYNB","BK4581","MEDX","BK4585","BK4139","BK4007","BK4588","HBImain","UDN","LNGR","LENZ","159837","UUP","AGNG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}